What has research revealed about the pathogenesis of androgenetic alopecia, alopecia areata, and central centrifugal cicatricial alopecia as well as new potential therapeutics?
Introduction:
To those outside the world of dermatology, hair is sometimes perceived to be a cosmetic concern. Dermatologists know better. With a high psychosocial burden and limited or no treatments approved by the U.S. Food and Drug Administration (FDA), patients with a variety of life-altering hair loss conditions must often wade through a multitude of treatments — and even still — may only have partial or no response.
This month in DermWorld, dermatologist hair loss experts discuss advances in the pathogenesis and treatments for androgenetic alopecia, alopecia areata, and central centrifugal cicatricial alopecia (CCCA).
